{"id":1329,"date":"2022-02-28T09:57:33","date_gmt":"2022-02-28T08:57:33","guid":{"rendered":"http:\/\/wordpress.p610862.webspaceconfig.de\/uber-mich\/"},"modified":"2022-03-18T15:49:47","modified_gmt":"2022-03-18T14:49:47","slug":"uber-mich","status":"publish","type":"page","link":"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/","title":{"rendered":"\u00dcber mich"},"content":{"rendered":"
<\/div>
<\/div>

\u00dcBER MICH<\/p>\n<\/div><\/div>

<\/div><\/div>

IHR HAUTARZT IN WIEN 1030<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

IHR HAUTARZT IN WIEN 1030<\/p>\n<\/div><\/div>

Martina Sanlorenzo MD, PhD<\/p>\n<\/div><\/div>

<\/i><\/div><\/div>
<\/i><\/div><\/div>

Ein bisschen \u00fcber mich<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

<\/div><\/div>

CURRICULUM VITAE<\/p>\n<\/div><\/div>

\"\"<\/div><\/div><\/div>

Ich habe Medizin studiert und danach die Ausbildung zur Dermatologin (Hautarzt)<\/strong> gemacht. Neben meiner klinischen Arbeit habe ich mich mit der Forschung befasst und an der Universit\u00e4t Turin in Italien den Doktortitel f\u00fcr Molekularmedizin<\/strong> erhalten.<\/p>\n<\/div><\/div>

During my residency I worked for two years at the Department of Dermatology \u2013
\nDepartment of Dermatology an der University of San Francisco in Kalifornien (USA) gearbeitet.<\/strong>.<\/p>\n<\/div><\/div>

Dar\u00fcber hinaus habe ich auch als Klinikerin und Forscherin gearbeitet und ich hatte die Ehre, f\u00fcr meine Forschung mit dem L\u2019Oreal-Unesco Price for Women in Science<\/a> \u2013 a highly competitive price supporting
\nwomen in science \u2013 for my research in melanoma.<\/p>\n<\/div><\/div>

2016 zog ich nach Wien und trat der Gruppe von Prof. Maria Sibilia am Institut f\u00fcr Krebsforschung der Medizinischen Universit\u00e4t Wien<\/strong> bei. Ich fokussierte mich auf die Entwicklung neuer Behandlungsm\u00f6glichkeiten f\u00fcr PatientInnen mit Melanom(en).<\/p>\n<\/div><\/div>

Ich bin mit einem kroatisch-\u00f6sterreichischen Dermatologen (Dr. Igor Vujic) verheiratet und
\nwir haben zwei wundersch\u00f6ne aber sehr lebhafte (!) Kinder.<\/p>\n<\/div><\/div>

Ich spreche Englisch, Italienisch, Deutsch und Bosnisch\/Kroatisch\/Serbisch<\/strong> , und ich
\nfreue mich immer wenn ich mit meinen Patienten in Ihrer Sprache reden kann.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

IHR HAUTARZT IN WIEN 1030<\/p>\n<\/div><\/div>

BUCHEN SIE EINEN TERMIN BEI IHREM HAUTARZT DR. MARTINA SANLORENZO<\/p>\n<\/div><\/div>

<\/i><\/div><\/div>
<\/i><\/div><\/div>

Um einen Termin zu vereinbaren, k\u00f6nnen Sie uns per Telefon<\/a> , E-Mail<\/a> , Nachricht<\/a>.<\/p>\n<\/div><\/div>

Das Team spricht flie\u00dfend Englisch<\/strong>, Italienisch<\/strong> und Deutsch<\/strong>.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

EINEN TERMIN BUCHEN<\/span><\/a><\/div>
ALLE BEHANDLUNGEN ENTDECKEN<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
[vc_raw_html css=“%7B%22default%22%3A%7B%22position%22%3A%22absolute%22%2C%22top%22%3A%22-26px%22%7D%7D“ el_class=“cus-raw-icon“]JTNDYSUyMGhyZWYlM0QlMjJodHRwcyUzQSUyRiUyRnB1Ym1lZC5uY2JpLm5sbS5uaWguZ292JTJGJTNGdGVybSUzRHNhbmxvcmVuem8lMkJtJTI2c29ydCUzRGRhdGUlMjIlM0UlM0NpJTIwYXJpYS1oaWRkZW4lM0QlMjJ0cnVlJTIyJTIwY2xhc3MlM0QlMjJmYXIlMjBmYS1jaGVjay1jaXJjbGUlMjIlM0UlM0MlMkZpJTNFJTNDJTJGYSUzRQ==[\/vc_raw_html]

Dr. Sanlorenzo auf PubMed<\/a><\/p>\n<\/div><\/div><\/div>

[vc_raw_html css=“%7B%22default%22%3A%7B%22position%22%3A%22absolute%22%2C%22top%22%3A%22-26px%22%7D%7D“ el_class=“cus-raw-icon“]JTNDYSUyMGhyZWYlM0QlMjJodHRwcyUzQSUyRiUyRnNjaG9sYXIuZ29vZ2xlLmNvbSUyRmNpdGF0aW9ucyUzRnVzZXIlM0RaQVJheUhJQUFBQUolMjZobCUzRGl0JTI2b2klM0RhbyUyMiUzRSUzQ2klMjBhcmlhLWhpZGRlbiUzRCUyMnRydWUlMjIlMjBjbGFzcyUzRCUyMmZhciUyMGZhLWVkaXQlMjIlM0UlM0MlMkZpJTNFJTNDJTJGYSUzRQ==[\/vc_raw_html]

Dr. Sanlorenzo<\/a>
\nauf Google Scholar<\/a><\/p>\n<\/div><\/div><\/div>

[vc_raw_html css=“%7B%22default%22%3A%7B%22position%22%3A%22absolute%22%2C%22top%22%3A%22-26px%22%7D%7D“ el_class=“cus-raw-icon“]JTNDYSUyMGhyZWYlM0QlMjIlMjNwcml6ZXMlMjIlM0UlM0NpJTIwYXJpYS1oaWRkZW4lM0QlMjJ0cnVlJTIyJTIwY2xhc3MlM0QlMjJmYXIlMjBmYS1nZW0lMjIlM0UlM0MlMkZpJTNFJTNDJTJGYSUzRQ==[\/vc_raw_html]

Dr. Sanlorenzo<\/a>
\nPreise<\/a><\/p>\n<\/div><\/div><\/div>

[vc_raw_html css=“%7B%22default%22%3A%7B%22position%22%3A%22absolute%22%2C%22top%22%3A%22-26px%22%7D%7D“ el_class=“cus-raw-icon“]JTNDYSUyMGhyZWYlM0QlMjIlMjNwdWJsaWNhdGlvbnMlMjIlM0UlM0NpJTIwYXJpYS1oaWRkZW4lM0QlMjJ0cnVlJTIyJTIwY2xhc3MlM0QlMjJmYXIlMjBmYS1zdGFyJTIyJTNFJTNDJTJGaSUzRSUzQyUyRmElM0U=[\/vc_raw_html]

Dr. Sanlorenzo<\/a>
\nwissenschaftliche<\/a>
\nPublikationen<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

[vc_raw_html css=“%7B%22default%22%3A%7B%22position%22%3A%22absolute%22%2C%22top%22%3A%22-26px%22%7D%7D“ el_class=“about-sec-cus-raw-icon“]JTNDaSUyMGFyaWEtaGlkZGVuJTNEJTIydHJ1ZSUyMiUyMGNsYXNzJTNEJTIyZmFyJTIwZmEtZ2VtJTIyJTNFJTNDJTJGaSUzRQ==[\/vc_raw_html]

PREISE<\/p>\n<\/div><\/div><\/div>

    \n
  • First poster prize at the 22nd National Congress Italian Melanoma Intergroup (IMI) (November 2016)<\/li>\n<\/ul>\n<\/div><\/div>
      \n
    • Eli Lily Grant to attend the 25th European Academy of Dermatology and Venereology (EADV) congress (September 2016)<\/li>\n<\/ul>\n<\/div><\/div>
        \n
      • L\u2019Oreal-UNESCO Italy \u2013 For Women in Science 2015-2016 Fellowship (June 2016)<\/li>\n<\/ul>\n<\/div><\/div>
          \n
        • Euroderm Excellence 2015 (November 2015)<\/li>\n<\/ul>\n<\/div><\/div>
            \n
          • 24th European Academy of Dermatology and Venereology (EADV) congress fellowship (October 2015)<\/li>\n<\/ul>\n<\/div><\/div>
              \n
            • Society of Investigative Dermatology (SID) Kligman Travel Fellowship (May 2015)<\/li>\n<\/ul>\n<\/div><\/div>
                \n
              • SIDeMaST price to attend the 42nd Annual European Society for Dermatological Research (ESDR) Meeting in Venice (February 2012)<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
                [vc_raw_html css=“%7B%22default%22%3A%7B%22position%22%3A%22absolute%22%2C%22top%22%3A%22-26px%22%7D%7D“ el_class=“about-sec-cus-raw-icon“]JTNDaSUyMGFyaWEtaGlkZGVuJTNEJTIydHJ1ZSUyMiUyMGNsYXNzJTNEJTIyZmFzJTIwZmEtc3RhciUyMiUzRSUzQyUyRmklM0U=[\/vc_raw_html]

                WISSENSCHAFTLICHE PUBLIKATIONEN<\/p>\n<\/div><\/div><\/div>

                  \n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, Gastaldi T, Hammer M, Fari O, de Sa Fernandes C, Csizer A, Monshi B, Rappersberger K, Sibilia M. Combined oral and topical TLR7\/8 agonists treatment promotes effective in-situ<\/em> tumor vaccination and synergizes with PD1 checkpoint blockage. 2021 Mar \u2013 submitted<\/li>\n
                • Stanganelli I, De Felici MB, Mandel VD, Caini S, Raimondi S, Corso F, Bellerba F, Quaglino P,Sanlorenzo M<\/u><\/strong>, Ribero S, Medri M, Farnetani F, Feliciani C, Pellacani G, Gandini S; IMI the Italian Melanoma Intergroup. The association between pesticide use and cutaneous melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):691-708.<\/li>\n
                • Posch C, Sanlorenzo M<\/u><\/strong>, Ma J, Kim ST, Zekhtser M, Ortiz-Urda S. MEK\/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and \u2018wild type\u2019 melanomas. Oncotarget. 2018 Oct 9;9(79):34990-34995.<\/li>\n
                • Vujic I, Gandini S, Stanganelli I, Fierro MT, Rappersberger K, Sibilia M, Tosti G, Ferrucci PF, Caini S, De Felici MB, Pagliarello C, Quaglino P, Sanlorenzo M<\/u><\/strong>; on behalf of IMI, the Italian Melanoma. A meta-analysis of melanoma risk in industrial workers. Melanoma Res. 2020 Jun;30(3):286-296.<\/li>\n
                • Ribero S, Malavenda O, Fava P, Astrua C, Marra E, Osella-Abate S, Sanlorenzo M<\/u><\/strong>, Caliendo V, Fierro MT, Quaglino P. BRAFi\/MEKi in patients with metastatic melanoma: predictive factors of complete response. Future Oncol. 2018 Sep 10. doi: 10.2217\/fon-2018-0386.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, Esteve-Puig R, Lai K, Vujic M, Lin K, Posch C, Dimon M, Moy A, Zekhtser M, Johnston K, Gho D, Ho W, Gajjala A, Oses Prieto J, Burlingame A, Daud A, Rappersberger K, Ortiz-Urda S. The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma. Sci Rep. 2018 Jul 19;8(1):10902.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, Floris A, Novelli M, Gammaitoni L, Giraudo L, Macagno M, Leuci V, Rotolo R, Donini C, Basiric\u00f2 M, Quaglino P, Fierro MT, Giordano S, Sibilia M, Carnevale-Schianca F, Aglietta M, Sangiolo D. BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody. Clin Cancer Res. 2018 Jul 15;24(14):3377-3385<\/li>\n
                • Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M<\/u><\/strong>, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y. Global patterns of care in advanced stage mycosis fungoides\/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann Oncol. 2017 Oct 1;28(10):2517-2525<\/li>\n
                • Vujic I, Herman R, Sanlorenzo M<\/u><\/strong>, Posch C, Monshi B, Rappersberger K, Richter L. Apremilast in psoriasis \u2013 a prospective real-world study. J Eur Acad Dermatol Venereol. 2018 Feb;32(2):254-259.<\/li>\n
                • Broganelli P, Ribero S, Castagno I, Ricceri F, Deboli T, Marra E, Tomasini C, Sacerdote C, Osella-Abate S, Sanlorenzo M<\/u><\/strong>, Quaglino P, Fierro MT. The large spectrum of spitzoid tumours: a retrospective survival study. G Ital Dermatol Venereol. 2017 Jul 11. doi: 10.23736\/S0392-0488.17.05575-4.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, De Giorgi V, Tomasini C, Deboli T, Quaglino P, Fierro MT, Broganelli P. Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation. Br J Dermatol. 2017 Nov;177(5):e209-e210.<\/li>\n
                • Richter L, Vujic I, Sesti A, Monshi B, Sanlorenzo M<\/u><\/strong>, Posch C, Rappersberger K. Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria. J Dtsch Dermatol Ges. 2017 Mar;15(3):309-317.<\/li>\n
                • Gammaitoni L, Giraudo L, Macagno M, Leuci V, Mesiano G, Rotolo R, Sassi F, Sanlorenzo M<\/u><\/strong>, Zaccagna A, Pisacane A, Senetta R, Cangemi M, Cattaneo G, Martin V, Coha V, Gallo S, Pignochino Y, Sapino A, Grignani G, Carnevale-Schianca F, Aglietta M, Sangiolo D. Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells. Clin Cancer Res. 2017 May 1;23(9):2277-2288.<\/li>\n
                • Dapavo P, Vujic I, Fierro MT, Quaglino P, Sanlorenzo M<\/u><\/strong>. The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis J Am Acad Dermatol. 2016 Oct;75(4):736-739.<\/li>\n
                • Posch C, Moslehi H, Sanlorenzo M<\/strong>, Green G, Vujic I, Panzer-Gr\u00fcmayer R, Rappersberger K, Ortiz-Urda S. Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo. Oncotarget. 2016 Jul 19;7(29):45916-45925.<\/li>\n
                • Ribero S, Balagna E, Sportoletti Baduel E, Picciotto F, Sanlorenzo M<\/u><\/strong>, Fierro MT, Quaglino P, Macripo G. Efficacy of electrochemotherapy for eruptive legs keratoacanthomas. Dermatol Ther. 2016 Sep;29(5):345-348.<\/li>\n
                • Posch C, Sanlorenzo M<\/u><\/strong>, Vujic I, Oses-Prieto JA, Cholewa BD, Kim ST, Ma J, Lai K, Zekhtser M, Esteve-Puig R, Green G, Chand S, Burlingame AL, Panzer-Gr\u00fcmayer R, Rappersberger K, Ortiz-Urda S. Phospho-proteomic analysis reveals increased CK2\u03b1 kinase activity in NRAS(Q61) mutant melanoma. J Invest Dermatol. 2016 Oct;136(10):2041-2048.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, Posch C, Ma J, Lin K, Lai K, Lee D, Vujic M, Oses-Prieto JA, Chand S, Rodriguez-Peralto JL, Burlingame A, Ortiz-Urda S. Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome. J Proteomics. 2016 Jul 20;144:140-7.<\/li>\n
                • Vujic I, Sanlorenzo M<\/u><\/strong>, Esteve-Puig R, Vujic M, Kwong A, Tsumura A, Murphy R, Moy A, Posch C, Monshi B, Rappersberger K, Ortiz-Urda S. Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells. Oncotarget. 2016 Feb 9;7(6):7297-306.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, Ortiz-Urda S. Time-Dependent Measurement of Adverse Events-Reply. JAMA Dermatol. 2015 Dec 1;151(12):1392-1393.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Ribero S, Osella Abate S, Mariani S, Strignano P, Salizzoni M, Savoia P, Fierro MT, Quaglino P. Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review. G Ital Dermatol Venereol. 2015 Oct 20. [Epub ahead of print]<\/li>\n
                • Posch C, Cholewa BD, Vujic I, Sanlorenzo M<\/u><\/strong>, Ma J, Kim ST, Kleffel S, Schatton T, Rappersberger K, Gutteridge R, Ahmad N, Ortiz-Urda S. Combined Inhibition of MEK and Plk1 has Synergistic Anti-Tumor Activity in NRAS Mutant Melanoma. J Invest Dermatol. 2015 Oct;135(10):2475-83<\/li>\n
                • Ribero S, Gualano MR, Osella-Abate S, Scaioli G, Bert F, Sanlorenzo M<\/u><\/strong>, Balagna E, Fierro MT, Macrip\u00f2 G, Sapino A, Siliquini R, Quaglino P. Histological regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis. JAMA Dermatol. 2015 Sep 2. doi: 10.1001\/jamadermatol.2015.2235.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Osella-Abate S, Ribero S, Marenco F, Nard\u00f2 T, Fierro MT, Novelli M, Cervetti O, Bernengo MG, Quaglino P. Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome. Int J Dermatol. 2015 Sep;54(9):1023-9.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, Daud A, Algazi A, Gubens M, Luna SA, Lin K, Quaglino P, Rappersberger K, Ortiz-Urda S. Pembrolizumab cutaneous adverse events and their correlation with disease progression. JAMA Dermatol. 2015 Jul 29.<\/li>\n
                • Ribero S, Osella-Abate S, Sanlorenzo M<\/u><\/strong>, Balagna E, Senetta R, Fierro MT, Macrip\u00f2 G, Macr\u00ec L, Sapino A, Quaglino P. Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? Ann Surg Oncol. 2015 Jun;22(6):1967-73<\/li>\n
                • Osella-Abate S, Ribero S, Sanlorenzo M<\/u><\/strong>, Maule MM, Richiardi L, Merletti F, Tomasini C, Marra E, Macrip\u00f2 G, Fierro MT, Quaglino P. Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. Int J Cancer. 2015 May 15;136(10):2453-7<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Vujic I, Posch C, Cleaver JE, Quaglino P, Ortiz-Urda S. The Risk of Melanoma in Pilots and Cabin Crew: UV Measurements in Flying Airplanes.JAMA Dermatol.2015 Apr;151(4):450-2<\/li>\n
                • Quaglino P, Fava P, Caproni M, Antiga E, De Simone C, Papini M, Parodi A, Novelli M, Osella-Abate S, Ribero S, Sanlorenzo M<\/u><\/strong>, Ponti R, Fierro MT, Marzano AV, Savoia P. Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group. J Eur Acad Dermatol Venereol. 2015 Mar 24<\/li>\n
                • Vujic I, Shroff A, Grzelka M, Posch C, Monshi B, Sanlorenzo M<\/u><\/strong>, Ortiz-Urda S, Rappersberger K. Mycoplasma pneumoniae-associated mucositis \u2013 case report and systematic review of literature. J Eur Acad Dermatol Venereol. 2015 Mar;29(3):595-8.<\/li>\n
                • Posch C, Latorre A, Crosby MB, Celli A, Latorre A, Vujic I, Sanlorenzo M<\/u><\/strong>, Green GA, Weier J, Zekhtser M, Ma J, Monico G, Char DH, Jusufbegovic D, Rappersberger K, Somoza \u00c1, Ortiz-Urda S. Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles. Biomed Microdevices. 2015 Feb;17(1):9908.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Wehner MR, Linos E, Kornak J, Kainz W, Posch C, Vujic I, Johnston K, Gho D, Monico G, McGrath JT, Osella-Abate S, Quaglino P, Cleaver JE, Ortiz-Urda S. The Risk of Melanoma in Pilots and Cabin Crew \u2013 A Meta-analysis. JAMA Dermatol. 2015 Jan;151(1):51-8.<\/li>\n
                • Vujic I, Sanlorenzo M<\/u><\/strong>, Posch C, Esteve-Puig R, Yen AJ, Kwong A, Tsumura A, Murphy R, Rappersberger K, Ortiz-Urda S. Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer. Oncotarget. 2015 Jan 20;6(2):969-78.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Choudhry A, Vujic I, Posch C, Chong K, Johnston K, Meier M, Osella-Abate S, Quaglino P, Daud A, Algazi A, Rappersberger K, Ortiz-Urda S. Comparative profile of cutaneous adverse events: BRAF\/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma. J Am Acad Dermatol. 2014 Dec;71(6):1102-1109.e1.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Ribero S, Osella-Abate S, Zugna D, Marenco F, Macrip\u00f2 G, Fierro MT, Bernengo MG, Quaglino P. Prognostic differences across sexes in melanoma patients: what has changed from the past? Melanoma Res. 2014 Dec; 24(6):568-76.<\/li>\n
                • Vujic I, Posch C, Sanlorenzo M<\/u><\/strong>, Yen AJ, Tsumura A, Kwong A, Feichtenschlager V, Lai K, Arneson DV, Rappersberger K, Ortiz-Urda SM. Mutant NRASQ61 shares signaling similarities across various cancer types \u2013 potential implications for future therapies. Oncotarget. 2014 Sep 15;5(17):7936-44.<\/li>\n
                • Latorre A, Posch C, Garcimart\u00edn Y, Celli A, Sanlorenzo M<\/u><\/strong>, Vujic I, Ma J, Zekhtser M, Rappersberger K, Ortiz-Urda S, Somoza \u00c1. DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. Nanoscale. 2014 Jul 7;6(13):7436-42.<\/li>\n
                • Posch C, Weihsengruber F, Bartsch K, Feichtenschlager V, Sanlorenzo M<\/u><\/strong>, Vujic I, Monshi B, Ortiz-Urda S, Rappersberger K. Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients. Br J Cancer. 2014 Mar 18;110(6):1427-32.<\/li>\n
                • Sanlorenzo M<\/u><\/strong>, Ribero S, Osella-Abate S, Balagna EM, Caliendo V, Macrip\u00f2 G, Bernengo MG, Quaglino P. Melanoma in younger patients under 20 years. G Ital Dermatol Venereol. 2013 Dec;148(6):667-72.<\/li>\n
                • Ribero S, Osella-Abate S, Sanlorenzo M<\/u><\/strong>, Savoia P, Astrua C, Cavaliere G , Tomasini C, Senetta R, Macrip\u00f2 G, Bernengo MG, Quaglino P. Favourable prognostic role of regression of primary melanoma in stage I-II AJCC patients. Br J Dermatol. 2013 Dec;169(6):1240-5.<\/li>\n
                • Ribero S, Quaglino P, Osella-Abate S, Sanlorenzo M<\/u><\/strong>, Senetta R, Savoia P, Macr\u00ec L, Macrip\u00f2 G, Sapino A, Bernengo MG. Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1132-7.<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"\u00dcBER MICH IHR HAUTARZT IN WIEN 1030 IHR HAUTARZT IN WIEN 1030 Martina Sanlorenzo MD, PhD Ein bisschen \u00fcber mich CURRICULUM VITAE Ich habe Medizin studiert und danach die Ausbildung zur Dermatologin (Hautarzt) gemacht. Neben meiner klinischen Arbeit habe ich mich mit der Forschung befasst und an der Universit\u00e4t Turin in Italien den Doktortitel f\u00fcr...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1329","page","type-page","status-publish","hentry"],"yoast_head":"\n\u00dcber mich - Dr. Martina Sanlorenzo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00dcber mich - Dr. Martina Sanlorenzo\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/\" \/>\n<meta property=\"og:site_name\" content=\"Dermatologist in Vienna 1030 \u2013 Dr. Martina Sanlorenzo\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-18T14:49:47+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"11\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/\",\"url\":\"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/\",\"name\":\"\u00dcber mich - Dr. Martina Sanlorenzo\",\"isPartOf\":{\"@id\":\"https:\/\/www.dermatologyvienna.com\/#website\"},\"datePublished\":\"2022-02-28T08:57:33+00:00\",\"dateModified\":\"2022-03-18T14:49:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.dermatologyvienna.com\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00dcber mich\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.dermatologyvienna.com\/#website\",\"url\":\"https:\/\/www.dermatologyvienna.com\/\",\"name\":\"Dermatologist in Vienna 1030 \u2013 Dr. Martina Sanlorenzo\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.dermatologyvienna.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00dcber mich - Dr. Martina Sanlorenzo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/","og_locale":"de_DE","og_type":"article","og_title":"\u00dcber mich - Dr. Martina Sanlorenzo","og_url":"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/","og_site_name":"Dermatologist in Vienna 1030 \u2013 Dr. Martina Sanlorenzo","article_modified_time":"2022-03-18T14:49:47+00:00","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"11\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/","url":"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/","name":"\u00dcber mich - Dr. Martina Sanlorenzo","isPartOf":{"@id":"https:\/\/www.dermatologyvienna.com\/#website"},"datePublished":"2022-02-28T08:57:33+00:00","dateModified":"2022-03-18T14:49:47+00:00","breadcrumb":{"@id":"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.dermatologyvienna.com\/de\/uber-mich\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dermatologyvienna.com\/de\/"},{"@type":"ListItem","position":2,"name":"\u00dcber mich"}]},{"@type":"WebSite","@id":"https:\/\/www.dermatologyvienna.com\/#website","url":"https:\/\/www.dermatologyvienna.com\/","name":"Dermatologist in Vienna 1030 \u2013 Dr. Martina Sanlorenzo","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dermatologyvienna.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/pages\/1329"}],"collection":[{"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/comments?post=1329"}],"version-history":[{"count":8,"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/pages\/1329\/revisions"}],"predecessor-version":[{"id":1821,"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/pages\/1329\/revisions\/1821"}],"wp:attachment":[{"href":"https:\/\/www.dermatologyvienna.com\/de\/wp-json\/wp\/v2\/media?parent=1329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}